Wealth Effects LLC Sells 4,000 Shares of Autolus Therapeutics plc (NASDAQ:AUTL)

Wealth Effects LLC reduced its stake in Autolus Therapeutics plc (NASDAQ:AUTL – Free Report) by 8.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 43,000 shares of the company’s stock after selling 4,000 shares during the period. Wealth Effects LLC’s […]

Related Keywords

,Nasdaq ,Wealth Effects ,Needham Company ,Nantahala Capital Management ,Exchange Commission ,Alyeska Investment Group ,Affinity Asset Advisors ,Autolus Therapeutics ,Free Report ,Capital Management ,Asset Advisors ,Therapeutics Trading Down ,Get Free Report ,Autolus Therapeutics Daily ,Nasdaq Autl ,Autl ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,